143
Views
13
CrossRef citations to date
0
Altmetric
Review

Treatment of resectable gastric cancer: current standards of care

&
Pages 135-142 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Si-sen Zhang, Li-hua Wu, Qing Liu, Kui-sheng Chen & Xie-fu Zhang. (2015) Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer. OncoTargets and Therapy 8, pages 633-640.
Read now

Articles from other publishers (12)

Peng‐Fei Zhang, Ze‐Dong Du, Feng Wen, Feng‐Yi Zhang, Wei‐Han Zhang, Li Luo, Jian‐Kun Hu & Qiu Li. (2020) Development and validation of a nomogram for predicting overall survival of gastric cancer patients after D2R0 resection. European Journal of Cancer Care 29:5.
Crossref
Amato Antonio Stabile Ianora, Michele Telegrafo, Nicola Maria Lucarelli, Valentina Lorusso, Arnaldo Scardapane, Artor Niccoli Asabella & Marco Moschetta. (2017) Comparison between CT Net enhancement and PET/CT SUV for N staging of gastric cancer: A case series. Annals of Medicine and Surgery 21, pages 1-6.
Crossref
Keun-Wook Lee, Sung Sook Lee, Jun-Eul Hwang, Hee-Jin Jang, Hyun-Sung Lee, Sang Cheul Oh, Sang Ho Lee, Bo Hwa Sohn, Sang Bae Kim, Jae-Jun Shim, Woojin Jeong, Minse Cha, Jae-Ho Cheong, Jae Yong Cho, Jae Yun Lim, Eun Sung Park, Sang Cheol Kim, Yoon-Koo Kang, Sung Hoon Noh, Jaffer A. Ajani & Ju-Seog Lee. (2016) Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer. Clinical Cancer Research 22:24, pages 6228-6235.
Crossref
Kwang Bok Lee, Hua Jin, Shuai Ye, Byung Hyun Park & Soo Mi Kim. (2016) Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases. Oncotarget 7:45, pages 73473-73485.
Crossref
Seyed Mohammad Hossein Kashfi, Faegheh Behboudi Farahbakhsh, Ehsan Nazemalhosseini Mojarad, Kazem Mashayekhi, Pedram Azimzadeh, Sara Romani, Shaghayegh Derakhshani, Habib Malekpour, Hamid Asadzadeh Aghdaei & Mohammad Reza Zali. (2015) Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer. Tumor Biology 37:2, pages 2119-2126.
Crossref
C H Kwon, H J Park, J R Lee, H K Kim, T Y Jeon, H-J Jo, D H Kim, G H Kim & D Y Park. (2014) Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer. British Journal of Cancer 111:10, pages 1993-2002.
Crossref
Qi Zhang, Huiju Wang, Yingyu Ma, Jun Zhang, Xujun He, Jie Ma & Zhong-Sheng Zhao. (2014) Overexpression of Nedd9 is a prognostic marker of human gastric cancer. Medical Oncology 31:7.
Crossref
Mikhail Ter-Ovanesov, Suayib Yalcin, John Zalcberg, Simon Hitier, Yung-Jue Bang, Chew-Wun Wu & Arnaud Roth. (2013) Registry of gastric cancer treatment evaluation (REGATE): II treatment practice. Asia-Pacific Journal of Clinical Oncology 9:4, pages 373-380.
Crossref
XIU JUAN LI, EUN SUNG PARK, MAN HEE PARK & SOO MI KIM. (2013) 3,3′-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway. Oncology Reports 30:5, pages 2419-2426.
Crossref
Rajini Seevaratnam, Roberta Cardoso, Caitlin Mcgregor, Laercio Lourenco, Alyson Mahar, Rinku Sutradhar, Calvin Law, Lawrence Paszat & Natalie Coburn. (2011) How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer 15:S1, pages 3-18.
Crossref
Radoslaw Jaworski, Elfriede Bollschweiler, Arnulf H. Holscher, Stefan P. Monig, Jaroslaw Skokowski, Jacek Zielinski, Maciej Swierblewski, Andrzej Kopacz & Janusz Jaskiewicz. (2011) Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany. Gastric Cancer 14:3, pages 234-241.
Crossref
Jae Yong Cho, Jae Yun Lim, Jae Ho Cheong, Yun-Yong Park, Se-Lyun Yoon, Soo Mi Kim, Sang-Bae Kim, Hoguen Kim, Soon Won Hong, Young Nyun Park, Sung Hoon Noh, Eun Sung Park, In-Sun Chu, Waun Ki Hong, Jaffer A. Ajani & Ju-Seog Lee. (2011) Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer. Clinical Cancer Research 17:7, pages 1850-1857.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.